New York, NY – Kyowa Hakko has announced it has formed the HealthCare Product Development Center in Tsukuba, Japan, to focus on basic and application research, formulation and development, information services and marketing. The center will be under the direction of Kazuhiro Yamamoto for Kyowa Hakko in Tokyo, Japan.
The center, situated in the heart of the well-known research and science-based town often referred to as Tsukuba Science City, will be home to 40 Kyowa researchers dedicated to supporting new Kyowa product development.
“This is yet another way Kyowa is taking the lead to support our customer products by providing the necessary research, information and data,” says Karen E. Todd, R.D., Kyowa director of marketing. “Kyowa envisions a strong growth position with health care related ingredients by providing the technical and scientific expertise, state-of-the-art manufacturing facilities, marketing and sales savvy and large capacity distribution channels to launch new products,” says Todd. “We are actively researching leading nutritional ingredients and consistently developing new clinical and laboratory research which will be a major benefit for Kyowa Hakko customers in the U.S. and worldwide.”
Kyowa Hakko, maker of such branded ingredients as Cognizin™ citicoline, Lumistor™ and Hydrafend™, is an international health ingredients manufacturer and has become a world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. A pioneer in the development and application of fermentation technology, Kyowa Hakko has maintained a constant commitment to research, developing innovative products and quality management.
Kyowa Hakko offers manufacturers and formulators one of the industry’s most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.